SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BriaCell Announces Preclinical Data on Bria-OTS+ Cancer Immunotherapy

BriaCell announces preclinical data on its Bria-OTS+ cancer immunotherapy.

Related stories